1. Caval Valve Implantation for Treatment of Severe Tricuspid Regurgitation
- Author
-
Frederick Beckhoff, Eberhard Grube, Hans R. Figulla, Jan-Malte Sinning, Henryk Dreger, Joachim Schofer, Philipp Jakob, Alexander Lauten, Michael Laule, Karl Stangl, University of Zurich, and Lauten, Alexander
- Subjects
Male ,congenital, hereditary, and neonatal diseases and abnormalities ,medicine.medical_specialty ,Treatment outcome ,Hemodynamics ,610 Medicine & health ,Regurgitation (circulation) ,030204 cardiovascular system & hematology ,2705 Cardiology and Cardiovascular Medicine ,03 medical and health sciences ,Blood Vessel Prosthesis Implantation ,0302 clinical medicine ,Blood vessel prosthesis ,Internal medicine ,medicine ,Humans ,cardiovascular diseases ,030212 general & internal medicine ,Aged ,Aged, 80 and over ,Heart Failure ,Tricuspid valve ,business.industry ,Angiography ,medicine.disease ,Tricuspid Valve Insufficiency ,Blood Vessel Prosthesis ,medicine.anatomical_structure ,Treatment Outcome ,Ventricle ,Heart failure ,cardiovascular system ,Cardiology ,10209 Clinic for Cardiology ,Female ,Tricuspid Valve ,Venae Cavae ,Cardiology and Cardiovascular Medicine ,business ,Valve disease ,Echocardiography, Transesophageal - Abstract
Severe tricuspid regurgitation (TR) is a complex condition of the right ventricle and tricuspid valve apparatus and frequently associated with symptomatic heart failure and significant morbidity and mortality [(1)][1]. In contrast to other types of valve disease, TR is seldom an isolated valve
- Published
- 2017